Novel mouse models to investigate cdc6 in growth-control and cancer

Projektinformationen

MICHAELRUGAARDJENSEN

ID Finanzhilfevereinbarung: QLG1-CT-1999-51151

Projekt abgeschlossen

Startdatum 1 Januar 2000

Enddatum 31 Dezember 2001

Finanziert unter

• Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Gesamtkosten € 131 012,00

EU-Beitrag € 131 012,00

Koordiniert durch

ISTITUTO EUROPEO DI ONCOLOGIA SRL
Italy

Ziel

Establishment of novel mouse models, which either over express or are deficient for the E2F regulated gene cdc6 to investigate its role in cell cycle control, development and tumorigenesis.

Wissenschaftliches Gebiet

• medical and health sciences › clinical medicine › oncology

Programm/Programme

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Thema/Themen

• 1.1.1.-7. - Chronic and degenerative diseases, cancer, diabetes, cardivascular diseases and rare diseases

Aufforderung zur Vorschlagseinreichung

Data not available

Finanzierungsplan

RGI - Research grants (individual fellowships)

Koordinator

ISTITUTO EUROPEO DI ONCOLOGIA SRL

• EU-Beitrag: Keine Daten
• Adresse: Via Ripamonti 435 ; 20141 MILANO ; Italien
• Gesamtkosten: Keine Daten